Harry L Stannard (Harry Stannard)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Respiratory Tract

Clinical Evaluation

Computed Tomography

Top Venues

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Harry L Stannard, Paulina Koszalka, Nikita Deshpande, Yves Desjardins, Mariana Baz
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses 15 (12) (2023)
Harry L Stannard, Paulina Koszalka, Nikita Deshpande, Yves Desjardins, Mariana Baz
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses 15 (12) (2023)
Harry L Stannard, Paulina Koszalka, Nikita Deshpande, Yves Desjardins, Mariana Baz
Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses 15 (12) (2023)
Harry L Stannard, Edin J Mifsud, Steffen Wildum, Sook Kwan Brown, Paulina Koszalka, Takao Shishido, Satoshi Kojima, Shinnya Omoto, Keiko Baba, Klaus Kuhlbusch, Aeron C Hurt, Ian G Barr
Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model. Communications biology 5 (1) (2022)